Microfluidic Encapsulation of Pancreatic Islets with Improved Biopolymers For Type 1 Diabetes Cell Therapy
Roxane Crouigneau,
PhD,
CEA
The talk will present the results obtained in a project that aims at encapsulating human and neo-natal pig islets, using chemically modified alginates with improved mechanical and biocompatibility properties, for type 1 diabetes cell therapy. The encapsulation is done in microfluidics, which gives better results of microcapsules sphericity, monodispersity and size.
|
|
